{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:52:04Z","timestamp":1782852724854,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangxi Provincial Natural Science Foundation Key Project","award":["20232ACB206032"],"award-info":[{"award-number":["20232ACB206032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10495-026-02339-6","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T16:47:38Z","timestamp":1779641258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying Neddylation-modified features to assess prognosis and immune efficacy in hepatocellular carcinoma"],"prefix":"10.1007","volume":"31","author":[{"given":"Zitao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"issue":"10127","key":"2339_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet (London, England) 391(10127):1301\u20131314","journal-title":"Lancet (London, England)"},{"issue":"10","key":"2339_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/CM9.0000000000002641","volume":"136","author":"Z Wang","year":"2023","unstructured":"Wang Z, Qin H, Liu S, Sheng J, Zhang X (2023) Precision diagnosis of hepatocellular carcinoma. Chin Med J 136(10):1155\u20131165","journal-title":"Chin Med J"},{"issue":"4","key":"2339_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM et al (2023) Management of hepatocellular carcinoma: a review. JAMA Surg 158(4):410\u2013420","journal-title":"JAMA Surg"},{"issue":"1","key":"2339_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan YT, Zhang C, Wu J, Lu P, Xu L, Yuan H et al (2024) Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer 23(1):189","journal-title":"Mol Cancer"},{"issue":"1","key":"2339_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jiang Y, Luo Q, Li L, Jia L (2019) Neddylation: a novel modulator of the tumor microenvironment. Mol Cancer 18(1):77","journal-title":"Mol Cancer"},{"issue":"14","key":"2339_CR6","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.7150\/thno.78876","volume":"13","author":"ZX He","year":"2023","unstructured":"He ZX, Yang WG, Zengyangzong D, Gao G, Zhang Q, Liu HM et al (2023) Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics 13(14):5017\u20135056","journal-title":"Theranostics"},{"issue":"1","key":"2339_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yu Q, Li Z, Zhao Y, Sun Y (2024) Protein neddylation and its role in health and diseases. Signal Transduct Target Ther 9(1):85","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2339_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-021-01070-w","volume":"14","author":"YC Zheng","year":"2021","unstructured":"Zheng YC, Guo YJ, Wang B, Wang C, Mamun MAA, Gao Y et al (2021) Targeting neddylation E2s: a novel therapeutic strategy in cancer. J Hematol Oncol 14(1):57","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2339_CR9","first-page":"177","volume":"43","author":"B Zheng","year":"2024","unstructured":"Zheng B, Qian F, Wang X, Wang Y, Zhou B, Fang L (2024) Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy. J exp clinical cancer res CR 43(1):177","journal-title":"J exp clinical cancer res CR"},{"issue":"1","key":"2339_CR10","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1038\/s41467-023-39374-9","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun Y, Baechler SA, Zhang X, Kumar S, Factor VM, Arakawa Y et al (2023) Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. Nat Commun 14(1):3762","journal-title":"Nat Commun"},{"key":"2339_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01931-4","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun L, Peng X, Zhu J, Wu C, Zhu W et al (2024) PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer. Apoptosis. https:\/\/doi.org\/10.1007\/s10495-023-01931-4","journal-title":"Apoptosis"},{"key":"2339_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111279","volume":"121","author":"L Sun","year":"2024","unstructured":"Sun L, Liu Z, Wu Z, Wu Z, Qiu B, Liu S et al (2024) PSMD11 promotes the proliferation of hepatocellular carcinoma by regulating the ubiquitination degradation of CDK4. Cell Signal 121:111279","journal-title":"Cell Signal"},{"key":"2339_CR13","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5627","author":"T Wang","year":"2024","unstructured":"Wang T, Li X, Ma R, Sun J, Huang S, Sun Z et al (2024) Advancements in colorectal cancer research: unveiling the cellular and molecular mechanisms of neddylation (Review). Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2024.5627","journal-title":"Int J Oncol"},{"issue":"3","key":"2339_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ijc.32379","volume":"145","author":"S Zhou","year":"2019","unstructured":"Zhou S, Zhao X, Yang Z, Yang R, Chen C, Zhao K et al (2019) Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma. Int J Cancer 145(3):763\u2013774","journal-title":"Int J Cancer"},{"issue":"9","key":"2339_CR15","doi-asserted-by":"publisher","first-page":"10781","DOI":"10.1002\/cam4.5775","volume":"12","author":"J Adler","year":"2023","unstructured":"Adler J, Oren R, Shaul Y (2023) Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy. Cancer Med 12(9):10781\u201310790","journal-title":"Cancer Med"},{"issue":"6","key":"2339_CR16","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.celrep.2014.05.009","volume":"7","author":"H Ryu","year":"2014","unstructured":"Ryu H, Gygi SP, Azuma Y, Arnaoutov A, Dasso M (2014) SUMOylation of Psmd1 controls Adrm1 interaction with the proteasome. Cell Rep 7(6):1842\u20131848","journal-title":"Cell Rep"},{"issue":"2","key":"2339_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113075","volume":"413","author":"L Liu","year":"2022","unstructured":"Liu L, Liu A, Dong J, Zuo Z, Liu X (2022) Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 (PINK1). Exp Cell Res 413(2):113075","journal-title":"Exp Cell Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02339-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:54:14Z","timestamp":1782849254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02339-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2339"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02339-6","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"154"}}